168 related articles for article (PubMed ID: 32970828)
21. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide.
Costa PDSS; Maciel-Fiuza MF; Kowalski TW; Fraga LR; Feira MF; Camargo LMA; Caldoncelli DIO; Silveira MIDS; Schuler-Faccini L; Vianna FSL
Mem Inst Oswaldo Cruz; 2022; 117():e220039. PubMed ID: 36383784
[TBL] [Abstract][Full Text] [Related]
23. Short report: erythema nodosum leprosum lymphadenitis.
Fiallo P; Pesce C; Lenti E; Nunzi E
Am J Trop Med Hyg; 1995 Apr; 52(4):297-8. PubMed ID: 7741163
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
25. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
26. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
27. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
28. Use of thalidomide in leprosy.
Hooper M
BMJ; 1991 Nov; 303(6814):1404-5. PubMed ID: 1760622
[No Abstract] [Full Text] [Related]
29. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
30. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
Darlong J; Govindharaj P; Charles DE; Menzies A; Mani S
Lepr Rev; 2016 Jun; 87(2):211-20. PubMed ID: 30212168
[TBL] [Abstract][Full Text] [Related]
31. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
[No Abstract] [Full Text] [Related]
32. Comment on "Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon".
Prestigiacomo JF; Scollard DM
Am J Dermatopathol; 2019 Mar; 41(3):239. PubMed ID: 30801346
[No Abstract] [Full Text] [Related]
33. No role for thalidomide in the treatment of leprosy.
Crawford CL
J Infect Dis; 2006 Jun; 193(12):1743-4; author reply 1744-5. PubMed ID: 16703522
[No Abstract] [Full Text] [Related]
34. Does thalidomide have a role in leprosy?
Crawford CL
Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
[No Abstract] [Full Text] [Related]
35. Recurrent erythema nodosum leprosum leading to secondary renal amyloidosis and nephrotic syndrome in an Indian patient with lepromatous leprosy.
Ahuja R; Garg S; Barwad A; Subbiah A; Gupta V
Int J Dermatol; 2023 Sep; 62(9):e514-e517. PubMed ID: 37066445
[No Abstract] [Full Text] [Related]
36. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
37. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
Sampaio EP; Kaplan G; Miranda A; Nery JA; Miguel CP; Viana SM; Sarno EN
J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
[TBL] [Abstract][Full Text] [Related]
38. Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions.
Kaplan G
Lepr Rev; 2000 Dec; 71 Suppl():S117-20. PubMed ID: 11201867
[No Abstract] [Full Text] [Related]
39. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
40. Thalidomide--the way forward.
Gardner-Medwin JM; Powell RJ
Postgrad Med J; 1994 Dec; 70(830):860-2. PubMed ID: 7870630
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
